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Although our understanding of the causes and consequences of hypoglycaemia has improved greatly, 
prevention of hypoglycaemia in patients with diabetes remains a major challenge.1 Symptomatic mild and 
severe hypoglycaemia is not only associated with increased risk of cardiovascular events, all-cause 
hospitalisation, and all-cause mortality2 it is also linked to concerns about driving competence, socialisation 
issues, self -care capacity, serious falls, physical and cognitive status, and impairments in emotional 
wellbeing and quality of life. 3 Hypoglycaemia in any adult with diabetes must not only be viewed as a 
serious adverse drug event, but also as a failure of system process and clinical review by health-care 
organisations. Over the past decade, recognition of this problem has led to important changes in diabetes 
management including an increased awareness of hypoglycaemia among health professionals and more 
focused education for patients. However, based on data presented by Francesco Zacchardi and colleagues4 
in The Lancet Diabetes & Endocrinology, the impact of these changes has been limited. The authors report 
on the trends in admissions with hypoglycaemia in England over a10yearperiod (2005-14) and its impact on 
length of stay and mortality. There was an initial increase in admissions for hypoglycaemia between 2005 
and 2010 (from 7868 in 2005, to 11756 in 2010; 49% increase), followed by a modest decline in subsequent 
years (to 10 977 in 2014; 39% increase from baseline); similar trends have been reported in the USA.5 
Despite varying regional rates of admission, little preadmission review by general practitioners (which 
might preclude the need for hospital admission in many cases), and the presence of a moderate degree of 
comorbidity, patients admitted with hypoglycaemia in 2014 were often discharged within 24 h, 
experienced less in-hospital mortality and fewer were readmitted in the month after discharge when 
compared with those admitted in 2005. Thus, our admission policies might now be working well but the 
flood of admissions into hospital for hypoglycaemia continues. 
Although this is promising news for the UK National Health Service, the observed figures are likely to be an 
underestimate of the true extent of the problem. 
Severity of hypoglycaemia varies considerably and not all people experiencing a hypoglycaemic episode 
present to emergency departments. The occurrence of hypoglycaemia is also often documented by patient 
report, which, in the case of mild to moderate episodes, remains highly unreliable. 
Another important and worrying observation from the data by Zaccardi and colleagues is the high 
prevalence of hypoglycaemia in adults aged 60 years or older (72% of all admissions throughout the study 
period). In one European study6 nearly one in five of all emergency admissions to hospital in patients with 
type 2 diabetes aged 80 years or older was due to hypoglycaemia. A review of the clinical characteristics of 
those admitted revealed that half were demented, half were in renal failure, and their average HbA1< was 
lower than 40 mmol/mol, all of which represent risk factors for hypoglycaemia. The atypical presentation 
of hypoglycaemia in older adults, which includes nonspedfic symptoms such as weakness, dizziness, 
sleepiness, unsteadiness, or confusion, continues to be a neglected observation among health professional 
staff and may account for both a more severe episode developing and delayed treatment resulting in 
admission to hospital7. Such neuroglycopaenic symptoms can be mistaken for cognitive decline, and might 
be aggravated in older patients who often experience subjective unawareness of hypoglycaemia and an 
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attenuated blood glucose recovery.8 
Each health-care organisation should acknowledge that hypoglycaemia has a high public health burden and 
approach this concern using a cohesive strategy that incorporates patient and health professional 
education, rationalisation of treatments, use of therapies associated with lower risk of hypoglycaemia, and 
increased engagement with primary care providers. This approach has to be combined with the 
implementation of risk minimisation strategies, particularly in older people, that substantially reduce the 
risk of hypoglycaemia. These strategies can vary from routine evaluation of insulin self-administration 
abilities to the provision of a hypoglycaemic management kit in care homes, hospices, and palliative care 
units. Management strategies that involve carers and paramedical services should be explored to support 
patients outside the hospital and avoid unnecessary hospital admissions. 
What is clear is that a target-based management strategy using HbA1c as the sole indicator of treatment 
success is no longer ideal and in fact might lead to more harm than good.9 Alternatively, liberating HbA1c 
goals alone might not decrease the risk of hypoglycaemia, especially in older adults.10 Apart from 
structured education for all patients on insulin, glinides, and sulfonylureas, a more pragmatic approach 
would be to set individualised glycaemic targets based on the patient's functional status,11, 12 which helps 
to set realistic goals and avoid overtreatment. Future research using prospective studies (rather than 
retrospective observational ones) are needed to identify the key factors that precipitate hypoglycaemia by 
age group, and the factors that led to hospital admission. This must be combined with follow-up data that 
investigate what factors lead to improved clinical outcomes after the event. 
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